Skip to main content
I

Injectsense

Injectsense develops ultra-miniature, implantable digital health sensors that continuously monitor intraocular pressure and other vital parameters in glaucoma patients. This technology provides real-time data to physicians, enabling timely adjustments to treatment plans and improving patient outcomes.

Emeryville, United StatesFounded 201413500+ followers
Updated 4 months ago

Funding

$2.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Glaucoma management relies on infrequent intraocular pressure (IOP) measurements obtained during clinic visits, potentially missing critical pressure fluctuations that impact treatment effectiveness. Current methods offer limited insight into a patient's IOP profile between appointments, hindering timely intervention and personalized therapy adjustments.

Solution

Injectsense offers an autonomous, continuous, and wireless ultraminiature implantable sensor designed to monitor intraocular pressure (IOP) in glaucoma patients. The self-anchoring smart sensor is hermetically sealed, ensuring that tissue and fluids do not interfere with its ability to measure absolute pressure and other parameters inside the body. The sensor transmits real-time data to physicians, providing a comprehensive understanding of a patient's IOP profile and enabling timely adjustments to treatment plans. This technology aims to transform therapy effectiveness through continuous sensing and actionable data, ultimately improving patient outcomes.

Target Audience

The primary target audience includes ophthalmologists and glaucoma specialists seeking continuous, real-time IOP data to optimize treatment strategies, as well as patients requiring consistent monitoring due to glaucoma or related conditions.

Features

  • Ultra-miniature sensor designed for continuous, autonomous, and wireless monitoring of intraocular pressure
  • Customizable, self-anchoring platform suitable for measuring multiple parameters, including pressure, oxygenation, and motion
  • Hermetically sealed electronics to prevent interference from tissue and fluids
  • Wafer-scale packaging for high yields and scalability
  • Low-power chip design for extended device life
  • Telemetry capabilities for wireless data transmission
This profile is AI-generated and may contain inaccuracies.